Pages that link to "Q37807624"
Jump to navigation
Jump to search
The following pages link to Stem cells to treat muscular dystrophies – Where are we? (Q37807624):
Displaying 27 items.
- The quasi-parallel lives of satellite cells and atrophying muscle (Q26800207) (← links)
- Murine and Human Myogenic Cells Identified by Elevated Aldehyde Dehydrogenase Activity: Implications for Muscle Regeneration and Repair (Q28741359) (← links)
- Influence of immune responses in gene/stem cell therapies for muscular dystrophies (Q33736192) (← links)
- Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle (Q34002410) (← links)
- Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles (Q34106079) (← links)
- Pericytes at the intersection between tissue regeneration and pathology (Q34357219) (← links)
- UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation. (Q34567478) (← links)
- Duchenne muscular dystrophy: current cell therapies (Q35780806) (← links)
- Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A. (Q36027867) (← links)
- Emerging drugs for Duchenne muscular dystrophy (Q36363716) (← links)
- Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy (Q36761839) (← links)
- Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. (Q37963087) (← links)
- Prospects for translational regenerative medicine (Q37964395) (← links)
- Phospho-tyrosine phosphatase inhibitor Bpv(Hopic) enhances C2C12 myoblast migration in vitro. Requirement of PI3K/AKT and MAPK/ERK pathways (Q39172025) (← links)
- Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. (Q39345467) (← links)
- Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblasts (Q39562373) (← links)
- Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering. (Q41672087) (← links)
- The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies (Q42934738) (← links)
- Cellular Transplantation Alters the Disease Progression in Becker's Muscular Dystrophy (Q43118355) (← links)
- Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model (Q46190014) (← links)
- Programming gene and engineered-cell therapies with synthetic biology. (Q50034999) (← links)
- Cellular Therapy for Chronic Traumatic Brachial Plexus Injury (Q52587045) (← links)
- Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy. (Q55063443) (← links)
- Current Methods for Skeletal Muscle Tissue Repair and Regeneration. (Q55283275) (← links)
- 185th ENMC International Workshop: Stem/precursor cells as a therapeutic strategy for muscular dystrophies 3–5 June 2011, Naarden, The Netherlands (Q82747689) (← links)
- Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies (Q88046702) (← links)
- Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues (Q91783625) (← links)